A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic ...

Better-for-you food and beverage innovators are betting big on artificial intelligence to help drive product development, but active ingredients – a different kind of AI – are still steering the ship, ...

Pivotal findings for the off-the-shelf cell therapy surpassed William Blair’s expectations and sent Allogene Therapeutics’ stock up more than 50% in pre-market trading Monday morning.

Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the search to treat the most difficult, recalcitrant cases ...

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the ...

To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...

Background Neutrophils guarantee a prompt and robust host response to pathogens. Yet, overshooting neutrophil activation ...

Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells.

IPC participates in EDQM-EPAA symposium to explore, discuss animal free pyrogenicity testing in medicines: Shardul Nautiyal, Mumbai Monday, March 30, 2026, 08:00 Hrs [IST] The Ind ...